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Rat monoclonal antibody raised against cultured mouse bone marrow was used
to detect an antigenic determinant on a discrete population ofmouse mononuclear
phagocytes by indirect immunofluorescence. The antigen was expressed on ad-
herent, late-cultured bone marrow macrophages and chronic inflammatory peri-
toneal macrophages elicited by the injection of thioglycolate broth. Binding of
the antibody to resident peritoneal or alveolar macrophages, blood monocytes, or
freshly explanted bone marrow cells was not detected. Less than 10% of acute
inflammatory mononuclear phagocytes expressed the antigen. The antibody did
not bind detectably to lymphocytes, granulocytes, erythrocytes, fibroblasts, or the
cells of several murine tumor lines. Results suggesting binding to mast cells were
equivocal. The antigen was species, but not strain, specific. It was concluded that
maturation, at least, was required for expression of the antigen. Results suggested
that additional influences were also involved.
The mononuclear phagocyte system is func-
tionally heterogeneous (for reviews, see refer-
ences 19 and 21). One approach to the investi-
gation of such heterogeneity centers on the de-
tection of antigens that mark discrete popula-
tions of mononuclear phagocytes. Reagents di-
rected against such antigens would allow the
enrichment or depletion of antigenically distinct
populations, thereby fostering definitive analysis
of the functional role(s) that these cells may
have. Description by Kaplan and Mohanakumar
(8) of an antiserum that detected only macro-
phages that had been activated to kill tumor
cells has lent credibility to this approach.
The essential element in investigations of this
kind is an indicator reagent that is truly specific
for the subject antigen. Conventionally raised
antisera are notoriously difficult to render spe-
cific. However, the advent of the hybridoma
technique (10) has helped immeasurably in ov-
ercoming the problem of specificity. The meth-
odology allows production of so-called mono-
clonal antibody, with specificity for a single an-
tigenic determinant. Such highly specific probes
are potentially of great value in explaining prior
observations of functional heterogeneity among
mononuclear phagocyte populations.
Using the hybridoma technique, we have pro-
duced a monoclonal antibody that marks a dis-
crete population of mononuclear phagocytes.
The following remarks characterized this anti-
body and the population of cells to which it
binds.
MATERIALS AND METHODS
Animals. Mice of strains BALB/c, C57BL/6, and
C3H/HeN were obtained from ARS/Sprague-Dawley
(Madison, Wis.). Strain A/He and outbred Swiss mice
were purchased from Charles River Breeding Labo-
ratories (Wilmington, Mass.). All mice were used at 7
to 8 weeks of age. Eight-week-old Lewis rats were
obtained from Microbiological Associates (Walkers-
ville, Md.). Female New Zealand white rabbits were
purchased from Dutchland Laboratory Animals, Inc.
(Denver, Pa.). Golden hamsters were the gift of F. W.
Henderson, Department of Pediatrics, of this institu-
tion.
Cells. Cells for antibody binding assay were har-
vested from cultures in mid-log-phase growth. BALB/
3T3 (1), L929 (American Type Culture Collection
CCL1), P815 mastocytoma (5), and MSC rhabdomy-
osarcoma (12) cell lines were carried antibiotic-free in
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(HEPES)-buffered (15 mM) modified Eagle minimal
essential medium (MEM) containing glutamine (2
mM) and fetal bovine serum (FBS; 10% final concen-
tration). The cultures were incubated in a humidified
atmosphere of 5% CO2 in air at 37°C. The mouse
myeloma line Sp2/O-Agl4 (16) was a gift from Ralph
Reisfeld (Research Institute of Scripps Clinic, La Jolla,
Calif.). Sp2/O cells were propagated in Dulbecco
MEM supplemented with FBS (20% final concentra-
tion) and 8-azaguanine (25 pg/ml) under a moist at-
mosphere containing 10% CO2 at 37°C. No evidence of
mycoplasma contamination was found by culture or
fluorescent dye analysis of cells for extranuclear de-
oxyribonucleic acid (4).
Resident peritoneal macrophages were harvested
from unstimulated animals by peritoneal lavage, as
described by Ruco and Meltzer (15). Peritoneal exu-
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dates were elicited with either purified, phenol-ex-
tracted lipopolysaccharide (13) from Escherichia coli
(O111:B4), a gift of David Morrison (Department of
Microbiology, School of Medicine, Emory University,
Atlanta, Ga.), or Brewer modified thioglycolate broth
(Difco Laboratories, Detroit, Mich.). Mice injected
with lipopolysaccharide were given 50 ng intraperito-
neally. Exudates were harvested by peritoneal lavage
at times indicated in the text. Thioglycolate broth was
injected intraperitoneally, either 1 or 4 days before
cells were harvested, by peritoneal lavage. The dose
was 3 ml for mice, 5 ml for rats and hamsters, and 15
ml for rabbits.
To obtain resident alveolar macrophages, a catheter
was inserted into the trachea. The lungs were then
flushed with 10 ml of MEM containing heparin (2 U/
ml) (14).
Spleen, thymus, and mesenteric lymph nodes were
removed aseptically and separately teased in ice-cold
medium to prepare single-cell suspensions.
Liquid bone marrow culture. The protocol of
Buhles and Shifrine (3) was followed. Briefly, mice
were treated with cyclophosphamide (Sigma Chemical
Co., St. Louis, Mo.) to increase the number of mono-
nuclear phagocyte colony-forming cells in their bone
marrows. An initial dose of 250 mg/kg was given
subcutaneously, after which repeated doses of 50 mg/
kg were administered every other day, beginning at
day 3, until day 17. Bone marrow was harvested on
day 19 by flushing the femora and tibiae. Nucleated
cells (5 x 106) were seeded into 10 ml of bone marrow
growth medium (MEM plus 10% FBS, 10% L-cell
conditioned medium, and 5% horse serum) contained
in a 100-mm diameter, tissue culture-grade petri dish.
After 3 to 4 days, plates were washed to remove loosely
adherent granulocyte colonies. Mononuclear phago-
cyte colonies were more tightly adherent and, conse-
quently, remained attached to the plastic during wash-
ing. Mononuclear phagocytes were removed by using
a rubber policeman. At least 95% of the recovered cells
were of the mononuclear phagocyte series, as deter-
mined by esterase staining (6).
Production of monoclonal antibodies. A Lewis
rat was injected intramuscularly with 107 bone marrow
culture-derived mouse mononuclear phagocytes sus-
pended in complete Freund's adjuvant. Three intra-
peritoneal injections (10' cells each, in saline) followed
at weekly intervals, after which the rat was rested for
8 weeks. A final exposure (2 x 106 mononuclear phag-
ocytes intravenously and 107 intraperitoneally) was
then given. The rat was killed 3 days later, and its
spleen was excised aseptically.
Mouse myeloma cells (Sp2/0-Agl4) were fused with
the rat's spleen cells, using 30% polyethylene glycol
1500 (BDH Chemicals Limited, distributed by Gallard-
Schlesinger Chemical Manufacturing Corp., Carle
Place, N.Y.) dissolved in Dulbecco MEM by the
method of Kennett et al. (9). The next day, cells were
distributed into flat-bottomed wells of microtest plates
(no. 3596, Costar, Cambridge, Mass.) in Dulbecco
MEM supplemented with HAT (1 x 10- M hypoxan-
thine, 4 X 10-7 M aminopterin, and 3 x 106 M
thymidine). Every other day, half of the medium was
removed from each well and replaced with fresh HAT-
containing medium. Approximately 14 days after fu-
sion, macroscopic evidence of cell growth appeared in
some of the wells (ultimately 394 of 2,000). An indirect
binding assay was used to detect antibody production
by individual outgrowths (11). Supernatants were
tested directly from wells, i.e., without cloning. Anti-
body was detected by incubating supernatants with
indicator cells (either bone marrow-derived mononu-
clear phagocytes or BALB-3T3 cells), then with rabbit
anti-rat immunoglobulin and, finally, with staphylo-
coccal protein A (Pharmacia Fine Chemicals, Inc.,
Piscataway, N.J.) labeled with '"I. Eighty-seven of
the 394 wells contained antibody that bound to mono-
nuclear phagocytes but not to 3T3 cells. The hybrid
populations from these 87 wells were expanded and
stored frozen in liquid nitrogen. They were then indi-
vidually thawed and cloned by limiting dilution.
Typing antisera Class- and subclass-specific an-
tisera raised against rat immunoglobulins were pur-
chased from Miles Research Products (Elkhart, Ind.).
Antisera to rat immunoglobulin G (IgG), IgM, and
IgG2b were produced in rabbits. Antisera against
IgG2a and IgG2c were produced in goats. Antiserum
against rat IgG1 was raised in sheep.
Indirect fluorescence microscopy. All staining
and washing procedures were conducted on ice. Cells
in suspension (except adherent bone marrow cells
which were attached to cover slips) were exposed to
either clone or Sp2/0-Agl4 myeloma cell supernatants
for 30 min. After two washes in Hanks balanced salt
solution, fluoresceinated F(ab')2 rabbit anti-rat im-
munoglobulin (2) was used as the developing reagent.
This reagent had been absorbed with mouse spleen
and resident peritoneal cells to remove all vestiges of
anti-mouse immunoglobulin and macrophage activi-
ties. After three additional washes in Hanks balanced
salt solution, cells were examined with a phase/fluo-
rescence microscope. Cells incubated with control
Sp2/0 supernatant followed by fluoresceinated F(ab')2
rabbit anti-rat immunoglobulin were absolutely nega-
tive for membrane fluorescence in every instance.
RESULTS
Characterization of antibody-producing
clone 54-2. Preliminary examination by indirect
immunofluorescence indicated that antibody
produced by the 54th hybrid outgrowth stained
mononuclear phagocyte populations differen-
tially. These cells were therefore selected for
further study. The cells were cloned by limiting
dilution to ensure that the observed reactivity
was the result of a monoclonal product. The
clone with the highest reactivity (designated Cl
54-2) was selected and expanded for use.
The stability of Cl 54-2 with regard to anti-
body production was assessed by subcloning. In
this experiment, 5 of 10 subclones continued to
produce antibody, indicating a degree of insta-
bility. In view of this finding, large numbers of
producer cells were stored frozen in liquid nitro-
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gen. Thawed cells have continued to produce
antibody of the same specificity.
The class and subclass of rat antibody pro-
duced by Cl 54-2 was determined by Ouchter-
lony analysis, using specific antisera. The anti-
body was identified as IgG2a by this approach.
Examination of bone marrow cells. Bone
marrow cells from cyclophosphamide-treated
mice were examined by indirect immunofluores-
cence, either directly or after liquid culture.
There was no detectable staining of the freshly
explanted cells by Cl 54-2 antibody. In culture,
expression of the relevant antigen developed
gradually on adherent cells, reaching a maxi-
mum of 73% positive by 4 days (Fig. 1A). The
cells that stained were mature-looking mono-
nuclear phagocytes as judged by phase-contrast
microscopy. The pattern of staining was that of
discrete membrane fluorescence, ranging in in-
tensity from brilliant to dim. Nonadherent cells,
which included immature mononuclear phago-
cytes and granulocytes, failed to bind the anti-
body detectably. Similar results were obtained
with bone marrow cells from mice that had not
been treated with cyclophosphamide (data not
shown).
To confirm that immature, nonadherent
mononuclear phagocytes would begin to express
the relevant antigen as they matured, nonadher-
ent cells from 4-day cultures were transferred
into fresh culture vessels. With time, a portion
of these cells adhered and began to express
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FIG. 1. Indirect immunofluorescence examination
of liquid cultured bone marrow cells with Cl 54-2
antibody. Symbols: 0, nonadherent cells; 0, adherent
cells. (A) Bone marrow was flushed from the tibiae
and femora of cyclophosphamide-treated mice. Cells
in bone marrow growth medium were plated into
petri dishes containing 12-mm-diameter glass cover
slips. At each time point, plates were agitated and
nonadherent cells were collected in the supernatant
medium. Cover slips bearing the adherentpopulation
were rinsed. Both adherent and nonadherent cells
were examined by indirect immunofluorescence. (B)
On day 4 of culture, as shown by the arrow, nonad-
herent cells were recovered, washed, and repeated as
in (A). Adherent and nonadherent cells were exam-
ined at 24-h intervals thereafter, as described above.
antigen (Fig. 1B). The maximal level of staining
reached was that which was seen in the original
culture. Again, granulocytes and other cells that
remained either loosely adherent or in suspen-
sion failed to stain detectably. These results
suggested that expression of the antigen de-
tected by Cl 54-2 antibody was associated with
maturation in culture. An alternative explana-
tion was that the antigen was acquired passively
from the culture medium. It was therefore im-
portant to determine whether mature mononu-
clear phagocytes that had never been in culture
bound the antibody.
Examination of resident peritoneal and
alveolar mononuclear phagocytes. Mature
mononuclear phagocytes were obtained by
either peritoneal or pulmonary lavage. The com-
position of each of these cell populations, as
determined by differential analysis, is given in
Table 1. Despite the high percentage of mono-
nuclear phagocytes in these suspensions, very
few cells stained (1.6% for the peritoneal cells
and 0.1% for those from the lung). The few cells
that did exhibit membrane fluorescence were
large and granular.
Examination ofacute and chronic inflam-
matory populations. The inflammatory re-
sponse alters mononuclear phagocytes morpho-
logically and functionally. Both acute and
chronic inflammatory populations of mononu-
clear phagocytes were examined, therefore, to
determine whether they would bind the mono-
clonal antibody produced by Cl 54-2. Table 2
shows the composition and staining properties
of the acute (24-h) and chronic (4-day) perito-
neal cell populations. Of the acute inflammatory
cells, either 2 or 8% stained, depending upon the
eliciting agent. In contrast to the low percentage
of staining detected in acute exudates, 86% of
the chronic inflammatory cells bound the mon-
oclonal antibody. It is important to note that
TABLE 1. Examination of resident peritoneal and
alveolar mononuclear phagocytes
Origin of Cells
Examination by: Perito- Lung
neal cav- (%)
ity(%
Indirect immnunofluorescence, cells 1.6 0.1
binding C1 54-2 antibody
Differential analysis
Mononuclear phagocytes 69 59
Lymphocytes 26 13
Granulocytesb 3 28
Mast cells 2 0
a As determined by differential analysis of Wright-
stained cytocentrifuge preparations.
b Both neutrophils and eosinophils.
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Indirect immunofluorescence, 2 8 86
cells binding Cl 54-2 antibody
Differential analysis
Mononuclear phagocytes 51 33 89
Lymphocytes 19 8 11
Neutrophils 23 56 0
Eosinophils 7 3 0
Mastcells 0 0 0
a Induced by the intraperitoneal injection of either 50 ng of
lipopolysaccharide (LPS) or 3 ml of Brewer modified thiogly-
colate broth (Thio) 24 h before cells were harvested by peri-
toneal lavage.
' Induced by the intraperitoneal injection of 3 ml of Brewer
modified thioglycolate broth 4 days before cells were harvested
by peritoneal lavage.
'As determined by differential analysis of Wright-stained
cytocentrifuge preparations.
none of these cells had been exposed to the
tissue culture reagents that were used to culture
mouse bone marrow. Furthermore, an F(ab')2
fragment prepared by pepsin digestion from the
monoclonal antibody continued to show similar
levels of staining when tested against thioglyco-
late-elicited macrophages (data not shown).
Examination of monocytes. The mononu-
clear phagocytes in inflammatory lesions are
derived predominantly from blood monocytes.
Because a few mononuclear phagocytes in acute
peritoneal exudates stained, it was necessary to
determine whether none, or a portion, of mono-
cytes bound the antibody produced by Cl 54-2.
Buffy-coat cells were isolated from mice with
cyclophosphamide-induced monocytosis (40%
monocytes) and examined in suspension by in-
direct immunofluorescence, using Cl 54-2 anti-
body. None stained detectably.
Examination of cell types other than
mononuclear phagocytes. Table 3 gives the
results of examining cell suspensions from a
variety of sources, each rich in cell types other
than mononuclear phagocytes. Very little stain-
ing was obtained with these populations. Thus,
it was possible to conclude that neither granu-
locytes, thymocytes, peripheralized lympho-
cytes, erythrocytes, nor cultured fibroblasts
bound the antibody in detectable amounts. As
before, the infrequent cell that stained was large
and granular.
The morphological appearance of the large,
granular cell suggested that it could be a mast
cell. To test this possibility, a drop of new meth-
ylene blue dye was allowed to diffuse under the
cover slip while the cell of interest, previously
located by indirect immunofluorescence, was ob-
served. In three of four attempts, the large gran-
ules stained metachromatically, thereby sup-
porting the hypothesis that these cells were mast
cells.
Thioglycolate-elicited macrophages of
mouse strains other than BALB/c. To de-
termine whether the antigenic determinant de-
tected by Cl 54-2 antibody was strain specific,
mice other than BALB/c (H-2d) were examined.
Mice of different histocompatibility types were
chosen, including C57BL/6 (H-2b), A/He (H.2a),
and C3H/HeN (H-2k). Outbred mice (Swiss)
were also examined. As for BALB/c mice, thio-
glycolate broth was injected 4 days before har-
vest of peritoneal exudates. Staining levels were
comparable in all mice tested (Table 4).
Peritoneal macrophages of species other
than mice. The peritoneal macrophages of rats
TABLE 3. Examination by indirect


















a Induced by intraperitoneal injection of 50 ng of
lipopolysaccharide (E. coli O111:B4) 6 h before cells
were harvested by peritoneal savage. Differential anal-
ysis of Wright-stained cytocentrifuge preparations:
37% mononuclear phagocytes, 19% lymphocytes, 40%
polymorphonuclear leukocytes, 4% mast cells.
TABLE 4. Examination of thioglycolate-elicited
peritoneal macrophages from several mouse
strains
Cells binding







a Induced by the intraperitoneal injection of 3 ml of
Brewer modified thioglycolate broth 4 days before
cells were harvested by peritoneal lavage.
b As determined by indirect immunofluorescence.
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(Lewis), golden hamsters, and rabbits (New Zea-
land white) were examined, with and without
thioglycolate elicitation. None of the cells bound
the monoclonal antibody, as detected by indirect
immunofluorescence.
DISCUSSION
This is the first report of a monoclonal anti-
body that detects an antigen that is expressed
by a discrete population of mouse mononuclear
phagocytes. It was detected, using a rat mono-
clonal antibody, on the surfaces of late-cultured
bone marrow mononuclear phagocytes and on
chronic (4-day) inflammatory macrophages elic-
ited by the intraperitoneal injection of thiogly-
colate broth. The antigen was not detectable on
resident peritoneal macrophages, alveolar mac-
rophages, or blood monocytes. Less than 10% of
acute inflammatory mononuclear phagocytes
bound the antibody detectably.
In contrast to our findings, the antigens de-
scribed in previous studies ofmononuclear phag-
ocytes were shared more broadly over the spec-
trum of mononuclear phagocyte differentiation.
For example, Mac-i (17) was found on bone
marrow cells and on spleen and blood mono-
cytes, as well as on mature splenic and thiogly-
colate-elicited peritoneal exudate macrophages.
In addition, macrophage antigens previously de-
tected by monoclonal antibodies have been
shared with either granulocytes (17) or lympho-
cytes (20). MSMA, a mouse macrophage-specific
antigen identified with conventionally prepared
antiserum (18), was found on splenic and peri-
toneal macrophages. A variety of other cell types
did not express the antigen; however, neutro-
phils were not examined. MSMA was also de-
tectable on the peritoneal macrophages of rats
and hamsters. By comparison, the antigen de-
tected in our studies was not found, at the level
of sensitivity of indirect fluorescence micros-
copy, on the mononuclear phagocytes of three
species other than mice, nor was it found on
granulocytes or lymphocytes. Whether Cl 54-2
antibody bound to mast cells will have to be
reexamined by using immunoelectron micros-
copy before a definite statement can be made, in
view of the facts that (i) populations which
contained significant numbers of mast cells
failed to show detectable binding (see 6-h peri-
toneal exudate, Table 3), (ii) P815 mastocytoma
cells failed to bind detectable levels of the anti-
body, (iii) not all of the large, granular, fluores-
cence-positive cells stained metachromatically,
and (iv) although strongly suggestive, metachro-
matic staining of granules is not conclusive evi-
dence that a cell is a mast cell.
One nonmonoclonal antiserum has been re-
ported to bind only to macrophages activated
for tumor cell killing (7, 8). Whether this reagent
was detecting one or a number of antigens on
activated cells cannot be determined from the
information that was given. Regardless of
whether an antigen or antigens were detected, it
is clear that this antiserum was defining a dis-
tinct, functional population of mononuclear
phagocytes.
The functional significance of the antigen de-
tected by Cl 54-2 is not yet known. Whatever it
is discovered to be, we find especially attractive
the possibility that the antigen may be a marker
for macrophages in chronic inflammatory sites.
Resident macrophages are present in the peri-
toneal cavity at the time inflammation is initi-
ated. Blood monocytes migrate into the perito-
neal cavity in response to inflammatory stimuli.
Either one or both of these populations, there-
fore, represented the progenitors of the cells that
eventually expressed the antigen in chronic in-
flammatory exudates. Neither resident macro-
phages nor the blood monocytes bound Cl 54-2
antibody detectably. Similarly, exudates col-
lected from acute inflammatory reactions did
not contain a high percentage of cells that were
positive for the antigen. Yet, in the presence of
a chronic irritant, thioglycolate broth for 4 days,
most of the macrophages bound Cl 54-2 anti-
body. Whether chronic inflammation provided
a positive signal to drive the cells to express the
antigen, or a closed site in which the cells were
freed from putative normal, negative controls, is
presently under study.
It is clear, however, that whichever of these
mechanisms is operative, it alone is insufficient
to cause expression of the antigen. Maturation
was additionally required. This conclusion can
be drawn from the experiments that are illus-
trated in Fig. 1, wherein nonadherent, immature
mononuclear phagocytes failed to express the
antigen in spite of its induction in the adherent,
mature population.
A final comment is needed regarding the ex-
tent to which artifact might be responsible for
our findings. The fact that the antigen recog-
nized by Cl 54-2 antibody was not found on a
variety of cultured cell types and was strongly
expressed on thioglycolate-elicited macrophages
that had never been in culture made it unlikely
that the antigen was acquired passively from the
tissue culture system. Conversely, the antigen
was not directly related to thioglycolate broth,
because mononuclear phagocytes in bone mar-
row culture bound the antibody. Finally, it is
also unlikely that antibody was binding to cells
via interaction with Fc receptors. The F(ab')2
fragment of Cl 54-2 antibody continued to show
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similar levels of staining with thioglycolate-elic-
ited mononuclear phagocytes as the whole an-
tibody.
In conclusion, we have described an antigen
that is expressed by a discrete population of
mouse mononuclear phagocytes. The finding of
one such marker increases the likelihood that
others may be identifiable by a similar approach.
Should such prove to be the case, it is our hope
that they will be of use in gaining a better
understanding of mononuclear phagocyte differ-
entiation and the biology of inflammation in
host defense.
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